IMPACT OF INFORMATIONAL CARE AND COMPLIANCE THERAPY ON TREATMENT OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Main Article Content
Keywords
Type 2 diabetes mellitus, informational care, compliance therapy, treatment outcome, glycemic control.
Abstract
Effective management of Type 2 diabetes mellitus (T2DM) emphasized patient education and adherence to treatment. This study evaluated the informational care and compliance therapy on glycemic control and treatment adherence among patients with T2DM.1, 2,3
Objective: To assess the effect of informational care and compliance therapy on glycemic parameters on medication adherence in patients with T2DM.
Methods: A randomized educational interventional study was conducted at Sohail Trust Hospital, Karachi, involving 100 patients with no-compliant T2DM. Participants were divided randomly into to intervention (n=50) and control (n=50). The interventional group was given standard treatment plus informational care and compliance therapy, while the control group was given standard care only. fasting blood sugar (FBS), and postprandial blood sugar (PPBS), and adherence (using the Mrisky-8 item scale) were measure at baseline, 6 weeks and 12 weeks. Data were analyzed using SPSS version 27 with independent t-tests, paired t-tests and chi-square tests. A p-value of < 0.005 was deemed statistically significant
Results: The Interventional group had significant decreased in FBS (from 141 mg/dL to 117 mg/dL) and PPBG (from 244 mg/dL to 179 mg/dL) (p<0.001), along with better adherence score (from 2.66 to 0.88). No significant changes were observed in the control group.
Conclusion: Informational care and compliance therapy significantly improve the glycemic control and treatment adherence among T2DM patients. These results suggest the adoption of educational interventions into normal diabetes care for better outcomes and complication prevention.
References
2. Basit, A., Fawwad, A., Qureshi, H., Shera, A. S., & International Diabetes Federation. (2024). Pakistan Diabetes Statistics & Prevalence. In IDF Diabetes Atlas (11th ed.). Retrieved from https://diabetesatlas.org/data-by-location/country/pakistan/
3. Megahed, F. I. A. L., Hassan, S. A. A., Abdelwahid, H. A., & Farg, H. K. (2021). Effect of lifestyle modification on glycemic control of type 2 diabetic patients at Suez Canal University Hospitals. In Psychology and Pathophysiological Outcomes of Eating (Akikazu Takada, Ed.). IntechOpen. https://doi.org/10.5772/intechopen.97738
4. “People with diabetes adherence to drug, dietary, and lifestyle changes in Erbil city, Iraq.” (2022). BMC Endocrine Disorders, 22, Article 305. https://doi.org/10.1186/s12902-022-01230-0
5. American Diabetes Association. (2024, December 9). The American Diabetes Association Releases Standards of Care in Diabetes—2025 [Press release]. ADA. https://diabetes.org/newsroom/press-releases/american diabetes association releases standards-care diabetes 2025.
6. Azeez, H., Khan, G., & Tahir, M. A. (2021). Contributing factors of non-adherence to anti-diabetic therapy: A cross-sectional study from Islamabad, Pakistan. Pakistan Armed Forces Medical Journal, 74(4), 7899–7904. https://doi.org/10.51253/pafmj.v74i4.7904
7. Polonsky, W. H., & Henry, R. R. (2016). Poor medication adherence in type 2 diabetes: Recognizing the scope of the problem and its key contributors. Patient Preference and Adherence, 10, 1299 1307. https://doi.org/10.2147/PPA.S106821
8. Al Qarni, A., Al Ajmi, N., Al Rabiah, F., et al. (2023). Factors contributing to noncompliance with diabetic medications and lifestyle modifications in patients with type 2 diabetes mellitus in the Eastern Province of Saudi Arabia: A cross sectional study. BMC Endocrine Disorders, 23, Article 210. https://doi.org/10.1186/s12902 023 01314 4
9. Pourhabibi, N., Sadeghi, R., Mohebbi, B., Shakibazadeh, E., Sanjari, M., & Yaseri, M. (2022). Factors affecting nonadherence to treatment among type 2 diabetic patients with limited health literacy: Perspectives of patients, their families, and healthcare providers. Journal of Education and Health Promotion, 11, Article 388. https://doi.org/10.4103/jehp.jehp_804_22
10. Ahmad, S., Ali, M., Ali, J., Khan, A., Khan, S., Ullah, Z., Rafiullah, & Hussain, S. (2025). Factors influencing adherence to recommended treatment among individuals with type 2 diabetes: A cross sectional study from Tertiary Hospital Swat, Pakistan. Frontier in Medical & Health Research, 3(5). Retrieved from https://fmhr.org/index.php/fmhr/article/view/541
11. Abbas, H., Hussain, W., & Qaisar, F. (2024). Non Adherence to Oral Diabetes Medication: Investigating the Role of Socioeconomic Factors and their Influence on Treatment Compliance. Esculapio – JSIMS, 19(04), 430 434. https://doi.org/10.51273/esc23.2513194112
12. Inada, M., Kobayashi, M., & Saito, H. (2021). Impact of Medication Adherence and Glycemic Control on the Risk of Micro and macrovascular diseases in Patients with Diabetes. Journal of Diabetes Research, 2021, Article 5539749. https://doi.org/10.1155/2021/5539749
13. Kunutsor, S. K., Seidu, S., & Khunti, K. (2024). Glycaemic control and macrovascular and microvascular outcomes: A systematic review and meta analysis of trials investigating intensive glucose lowering strategies in people with type 2 diabetes. Diabetes, Obesity & Metabolism, 26(4), 984–997. https://doi.org/10.1111/dom.15511
14. Holman, R. R., et al. (2008). Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 358(24), 2560–2572. https://doi.org/10.1056/NEJMoa0802987
15. Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009). Medication adherence: Its importance in Cardiovascular outcome. Circulation, 119(23), 3028-3035. https://doi.org/10.1161/CIRCULATIONAHA.108.768986
16. Cramer, J. A. (2004). A systematic review of adherence with medications for diabetes. Diabetes Care, 27(Supplement 1), S72-S77. https://doi.org/10.2337/diacare.27.2007.s72
17. Personalized interventions for diabetes management: Williams, R., Davies, M., & McEwan, P. (2022). Personalized type 2 diabetes management: An update on recent advances and recommendations. Diabetes Therapy, 13(6), 1021–1033. https://doi.org/10.1007/s13300-022-01189-7
18. Sadeghi, D. (2024). Improving adherence to treatment in patients with diabetes: Practical strategies. Endocrinology, Diabetes & Metabolism, 7(4), e00512. https://doi.org/10.1002/edm2.512
19. Davies, M. J., D'Alessio, D. A., Fradkin, J., Kernan, W. N., Kahn, R., Kolb, H., & Zinman, B. (2018). Management of hyperglycemia in type 2 diabetes, 2018. American Diabetes Association, 41(12), 2669-2701. https://doi.org/10.2337/dci18-0033

